每年研究成果
每年研究成果
個人檔案
教育/學術資格
PhD, Clinical Medicine, 國立陽明交通大學
指紋
查看啟用 I-Cheng Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy
Lee, P. C., Wu, C. J., Hung, Y. W., Lee, C. J., Mon, H. C., Chi, C. T., Lee, I. C., Kuo, Y. L., Chou, S. H., Luo, J. C., Hou, M. C. & Huang, Y. H., 2025, (Accepted/In press) 於: Hepatology.研究成果: Article › 同行評審
2 引文 斯高帕斯（Scopus） -
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy
Mon, H. C., Lee, P. C., Hung, Y. P., Hung, Y. W., Wu, C. J., Lee, C. J., Chi, C. T., Lee, I. C., Hou, M. C. & Huang, Y. H., 1月 2025, 於: Journal of Hepatology. 82, 1, p. 51-61 11 p.研究成果: Article › 同行評審
開啟存取19 引文 斯高帕斯（Scopus） -
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic Areas
Hung, Y. P., Lee, P. C., Chang, Y. H., Yang, M. H., Chiu, C. H., Chen, M. H., Lan, K. H., Lee, I. C., Hou, M. C., Chao, Y. & Huang, Y. H., 2月 2025, 於: Alimentary Pharmacology and Therapeutics. 61, 3, p. 501-512 12 p.研究成果: Article › 同行評審
開啟存取11 引文 斯高帕斯（Scopus） -
Letter: Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply
Wu, K. C. & Lee, I. C., 1月 2025, 於: Alimentary Pharmacology and Therapeutics. 61, 1, p. 232-233 2 p.研究成果: Letter › 同行評審
開啟存取 -
Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery
Hui, R. W. H., Chiu, K. W. H., Lee, I. C., Wang, C., Cheng, H. M., Lu, J., Mao, X., Yu, S., Lam, L. K., Mak, L. Y., Cheung, T. T., Chia, N. H., Cheung, C. C., Kan, W. K., Wong, T. C. L., Chan, A. C. Y., Huang, Y. H., Yuen, M. F., Yu, P. L. H. & Seto, W. K., 1 8月 2025, 於: Hepatology. 82, 2, p. 344-356 13 p.研究成果: Article › 同行評審
4 引文 斯高帕斯（Scopus）